Brazilian Journal of Pharmaceutical Sciences · 2011 · 13 citations · 21 references
MedicineToxicologyRadiation DosimetryRadiation ProtectionRadiobiologyBiological Effects Of RadiationRadiation BiologyRadiation HealthRadiation ToxicityRelative Biological EffectivenessTissue Responses To RadiationAcute Radiation InjuryHistopathological LesionsHistopathological ResponseHistopathological ToxicityRadiation DamageRadiation Dose EffectsRadiation-induced Organ DysfunctionTissue Radiation Injury
To investigate the effects of sanguinarine (SAN) on acute radiation induced injury in mice, 45 mice were randomly divided into control, 10 Gy and SAN+10 Gy groups. Mice in the 10 Gy and SAN+10 Gy groups were exposed to single X-ray radiation with an accumulated dose of 10 Gy. Mice in the SAN+10 Gy group were administered intraperitoneally with 2.5 mg/kg body weight of SAN before radiation. Five days after radiation exposure, 5 mice from each group were sacrificed and samples of the small intestine, lung, spleen and liver were fixed for histopathological examinations. Compared with the 10 Gy group, radiation sickness was obviously delayed or attenuated in the SAN+10 Gy group. Survival analysis showed a significant difference between 2 radiation groups (P<0.05) and mean survival time was 3 days longer in the SAN+10 Gy group than in the 10 Gy group (7.21±0.19 vs. 4.20±0.13, P<0.001). Radiation-induced organ damage, based on histopathological examinations, was decreased by SAN pretreatment. Chiu’s pathology grading scores, which is an index of intestinal damage, was significantly lower in the SAN+10 Gy group than in the 10 Gy group (2.77±0.48 vs. 4.37±0.31, P<0.01). A similar result was obtained in the pathological score of lung (1.67±0.21 vs. 2.33±0.38, P<0.01). Our preliminary findings demonstrated that SAN protects animals against radiation-induced sickness and acute damage to organs and following animal death.
21
Intestinal Mucosal Lesion in Low-Flow States
Chu-Jeng Chiu · Archives of Surgery · 1970 · 1.8K citations
Life Sciences, Pathology, Physiology +17
Erythropoietin regulates tumour growth of human malignancies
Y Yasuda · Carcinogenesis · 2003 · 257 citations
Medicine, Oncology, Pharmacology +10
Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma
Géza Ács, Paul J. Zhang, Timothy R. Rebbeck et al. · Cancer · 2002 · 156 citations · Full text
Medicine, Cell Biology, Oncology +17